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In the fission yeast Schizosaccharomyces pombe, the execution of Start requires the activity
of the Cdc2 protein kinase and the CdclO/Sctl transcription complex. The loss of any of
these genes leads to G1 arrest and activation of the mating pathway under appropriate
conditions. We have undertaken a genetic and biochemical analysis of these genes and
their protein products to elucidate the molecular mechanism that governs the regulation
of Start. We demonstrate that serine-196 of CdclO is phosphorylated in vivo and provide
evidence that suggests that phosphorylation of this residue is required for CdclO func-
tion. Substitution of serine-196 of CdclO with alanine (CdclO S196A) leads to inactivation
of CdclO. We show that CdclO S196A is incapable of associating with Sctl to form a
heteromeric complex, whereas substitution of this serine with aspartic acid (S196D)
restores DNA-binding activity by allowing CdclO to associate with Sctl. Furthermore, we
demonstrate that Cdc2 activity is required for the formation of the heteromeric Sctl/
CdclO transcription complex and that the CdclO S196D mutation alleviates this require-
ment. We thus provide biochemical evidence to demonstrate one mechanism by which
the Cdc2 protein kinase may regulate Start in the fission yeast cell cycle.
INTRODUCTION
In eukaryotes, the passage of cells through the cell
cycle is regulated in part by the association of mul-
tiple cyclin-dependent kinases (cdk) with different
cyclin regulatory subunits. In yeast, a single 34-kDa
cdk (Cdc2/CDC28) sequentially associates with G1,
S-phase, or mitotic cyclins to form active holoen-
zyme complexes and thereby direct distinct cell cy-
cle transitions. The developmental fate of the cell is
determined by a series of regulatory events in the G1
termed Start. At this control point, a cell monitors
both internal cues, such as cell size, and external
cues, such as nutrient availability, and subsequently
decides to proceed into a new round of mitotic cell
division or to exit the cell cycle by activating func-
tions leading to cellular differentiation.
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In Saccharomyces cerevisiae, passage through Start re-
quires the association of the CDC28 protein kinase
with positive regulatory subunits known as G1 cyclins,
CLNs. Three CLN type cyclins form a redundant mul-
tigene family that associates with the CDC28 protein
kinase to control passage through G1 (Richardson et
al., 1989). Whereas the activity of any CLN gene prod-
uct is sufficient to promote cell cycle progression, the
loss of all three CLN genes results in cell cycle arrest at
Start. In turn, overexpression of any CLN results in a
shortened G1 and accelerates passage through Start.
Thus, the decision to maintain mitotic cell cycle pro-
gression or to enter an alternative developmental fate
is controlled in part by the association of CDC28 with
CLN-type cyclins in G1.
Although the concept of cell cycle commitment at
Start has been useful in describing yeast cell physiol-
ogy, the underlying molecular basis of cell cycle com-
mitment remains unclear. It is likely that one role of
the Cdc2/CDC28 kinase in G1 is to directly activate
transcription factors involved in regulating genes re-
quired for the activation of DNA replication. In bud-
ding yeast, the SWI4 and SWI6 proteins have been
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identified as components of the SBF transcription
complex that is required for the CDC28 (Start) depen-
dent expression of the HO, CLN1, CLN2, HCS26, and
PCL2 (ORFD) genes at the G1 /S-phase boundary
(Breeden and Nasmyth, 1987a; Andrews and Hers-
kowitz, 1989a; Nasmyth and Dirick, 1991; Ogas et al.,
1991; Measday et al., 1994). The SWI4 and SWI6 pro-
teins have been implicated in the transcriptional con-
trol of the CLN1 and CLN2 genes through a positive
feedback loop (Cross and Tinkelenberg, 1991; Dirick
and Nasmyth, 1991; Ogas et al., 1991;). The CLN3/
CDC28 kinase complex is present throughout the cell
cycle, and consequently, it has been proposed that this
complex induces CLN1 and CLN2, which in turn
leads to an abrupt rise in CDC28 kinase activity that is
associated with the commitment of cells to enter the
S-phase (Cross and Tinkelenberg, 1991). Recent exper-
iments, however, have shown that CLN3 is normally
responsible for SBF-dependent transcription when
cells reach a critical size at Start (Dirick et al., 1995;
Stuart and Wittenberg, 1995). Activation of the SW14/
SW16 complex at Start is thus thought to require phos-
phorylation by one or more members of the CLN/
CDC28 family of kinases (Cross and Tinkelenberg,
1991; Tyers et al., 1993; Koch et al., 1996).
In the fission yeast S. pombe, three genes are known
to be required for the execution of Start. These encode
the Cdcl0 and Sctl /Resl transcription factors and the
Cdc2 protein kinase, which is also required in G2
(Nurse and Bisset, 1981, Tanaka et al., 1992, Caligiuri
and Beach, 1993). Haploid strains carrying inactivat-
ing mutations in any of these genes arrest in G, and
mate to form diploid cells under appropriate nutri-
tional conditions. CdclO and Sctl share amino acid
sequence similarity with the SWI4, SWI6, and MBP1
transcription factors from budding yeast (Aves et al.,
1985; Breeden and Nasmyth, 1987b; Andrews and
Herskowitz, 1989b; Tanaka et al., 1992; Caligiuri and
Beach, 1993; Koch et al., 1993). CdclO and Sctl function
together as a heteromeric transcription complex to
activate the expression of the cdc22, cdtl, and cdc18
genes at the G1-S-phase transition (Lowndes et al.,
1992a; Caligiuri and Beach, 1993; Hofmann and Beach,
1994; Kelley et al., 1993). Sctl and CdclO are thought to
be directed to the promoters of these periodically ex-
pressed genes by the presence of Mlu 1-like elements
(MCB) in their upstream regions, which have been
shown to be sufficient to confer cell cycle periodicity
on heterologous promoters (Lowndes et al., 1992a,b).
Sctl and CdclO are both expressed constitutively
throughout the cell cycle; however, the DNA-binding
activity of the transcription complex has been shown
to oscillate (M.C., unpublished observation; Aves et
al., 1985; Reymond et al., 1993). This activity is depen-
dent on Cdc2 function, thus phosphorylation of Sctl
or CdclO may contribute to the regulation of the com-
plex (Reymond et al., 1993).
Table 1. List of S. pombe strains
Strain Genotype
SP 201 h"' leul-32 ade6-210
SP 357 h-s cdc2-33 leul-32 ura4-D18 ade6-210
SP 812 h-S leul-32 ura4-dI8 ade6-210
SP 965 h-s cdcl0-129 leul-32 ura4-D18 ade6-210
SP 1296 h-s cdc2-M72 leul-32 ura4-D18 ade6-210
SP 1297 h-5 cdclO::ura4 sctl-l ura4-D18 leul-32
We have undertaken a biochemical and genetic
analysis of the Sctl /Cdcl0 transcription complex in S.
pombe. We demonstrate that Cdc2 kinase activity is
necessary for the formation of the CdclO/Sctl tran-
scription complex. An analysis of the primary struc-
ture of CdclO revealed a single canonical Cdc2 phos-
phorylation site. We show that this site, which
includes serine-196 (Ser-196), is phosphorylated in
vivo. Substitution of the serine residue within this site
with an alanine (S196A), thus preventing phosphory-
lation, led to the dissociation of the Cdc10/Sctl com-
plex. As a consequence, the CdclO S196A gene is inca-
pable of functioning in vivo. Substitution of this serine
with the negatively charged aspartic acid, thus poten-
tially mimicking phosphorylation, restored the ability
of CdclO to associate with Sctl and consequently to
function in vivo. Furthermore, we demonstrate that
Cdc2 kinase activity is essential for CdclO/Sctl com-
plex formation, and that the CdclO S196D mutant
bypasses this requirement. Thus, we provide bio-
chemical and genetic evidence to suggest one mecha-
nism by which the Cdc2 protein kinase may serve to
regulate Start in the fission yeast cell cycle.
MATERIALS AND METHODS
Strains and Media
All S. pombe strains were derived from a wild-type strain originally
described by Leupold (1970). The strains used in this study are
listed in Table 1. S. pombe was grown in standard YEA, YE, PM, and
PMA media containing additional amino acids when indicated at
75-150 ,ig/ml (Beach et al., 1985). The standard genetic procedures
previously described for S. pombe were followed (Gutz et al., 1974).
Immunoprecipitation and Western Blotting
S. pombe cell-free lysates were prepared essentially as described
(Booher et al., 1989). Cells were quickly disrupted by vortexing in
the presence of glass beads in buffer H [25 mM Tris, pH 7.5, 1 mM
dithiothreitol (DTT), 60 mM ,3-glycerol phosphate, 15 mM p-nitro-
phenylphosphate, 15 mM EGTA, 15 mM MgCl2, 0.1 mM NaF, 0.1
mM sodium orthovanadate and 0.1% Nonidet P-40 (NP-40), 1 mM
phenylmethylsulfonyl fluoride (PMSF), 2 ,ug/ml leupeptin, aproti-
nin, and pepstatin, 10 j.g/ml L-1-tosylamide-2-phenylethylchlorom-
ethyl, and 7-amino-1-chloro-3-tosylamido-2-heptanone]. After lysis,
an equal volume of cold buffer H was added to the beads, and lysate
was collected and centrifuged at 11,000 x g for 15 min. The super-
natant was collected, and the protein concentration was determined
by a colorimetric assay using Bradford reagent (Bradford, 1976).
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Immunoprecipitations were performed with 10-50 mg of soluble
protein extract and 1.0 ,ul of antibody as specified and were rotated
at 4°C. After 2 h, 20 ,ul of a 1:1 slurry of protein-A Sepharose
(Pharmacia Biotech, Piscataway, NJ) was added, and the incubation
was continued for an additional 30 min at 4°C. The immune com-
plexes were recovered by centrifugation and washed three times in
1.0 ml of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA,
0.5% NP-40, 1 mM DTT, and 1 mM PMSF. The samples were
resuspended in Laemmli buffer, and the proteins were resolved by
conventional SDS-PAGE.
For immunoblotting, the proteins were transferred to nitrocellu-
lose for 30 to 60 min at 400 mA with a semidry transfer apparatus
(Millipore, Bedford, MA). After the transfer, the immunoblots were
blocked in TBST (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05%
Tween 20) containing 5% nonfat dry milk for 30 min at 37°C. Blots
were incubated with a 1:1,000 dilution of antibody in TBST 5% milk
for 2 h at room temperature. The blots were washed three times (20
min each) in TBST and then incubated with a 1:50,000 dilution of an
anti-mouse or anti-rabbit Fc antibody as appropriate (Jackson Im-
munoResearch Laboratories, West Grove, PA) in TBST 5% milk for
1 h at room temperature. The proteins were visualized using an
enhanced chemiluminescence kit (Amersham Life Science, Arling-
ton Heights, IL) and conventional autoradiography.
Cdc25 Block Release
A strain (SP 530) carrying cdc25-22 was grown to mid-exponential
phase in rich medium (YEA) at 25'C, and the cells were collected by
centrifugation and inoculated into fresh media at 36°C for 3 h. The
culture was then shifted back to 25'C, and 50-ml aliquots of cells
were harvested at 30-min intervals. Cell extracts were prepared as
described above.
Metabolic Labeling and Two-Dimensional Tryptic
Peptide Mapping
S. pombe cells were grown for approximately 16 h in phosphate-free
minimal media in which the NaH2PO4 was reduced to 1 mM and
the potassium phthalate was replaced with sodium acetate (Moreno
et al., 1991). The cells were harvested, 5-10 ml at 1 X 107 cells per ml,
washed with H20, and resuspended in phosphate-free minimal
media supplemented with 50 ,tM NaH2PO4. The cultures were
incubated for 2 h before the addition of [P2P]orthophosphate (1
mCi/5 ml culture) and labeled for 3 to 4 h. Extracts were prepared
for immunoprecipitation as described above.
The proteins subjected to tryptic mapping were eluted from gel
slices in 50 mM ammonium bicarbonate ovemight in the presence of
20 ,ug of RNase. The proteins were precipitated with trichloroacetic
acid and digested with 10 ,ug of L-1-tosylamide-2-phenylethylchlo-
romethyl-trypsin as described (van der Geer et al., 1993). Peptide
maps were produced by two-dimensional separation of the phos-
phopeptides on TLC plates. The first dimension was electrophoresis
in pH 1.9 buffer, and the second dimension was chromatography in
isobutyric acid buffer (van der Geer et al., 1993).
Gel Retardation Assays
Cells were grown into a density of 5 x 106 to 1 X 107 cells/ml in
minimal selective media, harvested by centrifugation, and washed
once in lysis buffer (50 mM Tris, pH 7.5, 0.3 M KCl, 10% glycerol, 10
mM MgCl2, 20 mM 13-glycero-phosphate, 5 mM EDTA, 0.1 mM
sodium vanadate, 1 mM DTT, 0.2% NP40, 1 mM PMSF, 2 Ag/ml
leupeptin, aprotinin, and pepstatin). The cells were disrupted by
vortexing with glass beads. Cellular debris was cleared from the
lysate by centrifugation for 20 min in a microcentrifuge. The super-
natant was collected, and the protein concentration was determined
by a colorimetric assay using Bradford reagent (Bradford, 1976).
The restriction fragments to be used for probes were recovered
from low-melting-temperature agarose in Tris-acetate buffer and
end labeled with Klenow polymerase in the presence of
[a-32P]dATP (Sambrook et al., 1989). The binding reactions were
performed in a volume of 20 ,ul and contained 20 jig of lysate in 20
mM Tris (pH 7.5), 50 mM KCl, 10 mM MgCl2, 5% glycerol, 2 mM
DTT, 1 mM ATP, 0.1 mg/ml poly(dIdC)-poly(dIdC) (Pharmacia,
Piscataway, NJ). After the addition of the protein extracts, the
reaction mixtures were incubated at room temperature for 10 min.
Approximately 1 ng of probe at 107 cpm/,ug was added to the
binding reaction, and the incubation was continued for an addi-
tional 10 min. When noted, unlabeled promoter fragment, at an
approximately 50-fold M excess to the probe, was added at the same
time as the probe. The anti-CdclO antibody and preimmune sera
were diluted 10-fold in binding buffer, and 1 ,ul was added after the
binding reaction. The HAl monoclonal antibody 12CA1 (Boehr-
inger Mannheim, Indianapolis, IN) was purified on protein A-
Sepharose as described by the manufacturer. The antibody was
diluted 1:10 in binding buffer, and 1 ml was added to the reaction as
above. The binding reaction was incubated for an additional 10 min
after the addition of antibodies. The DNA protein complexes were
resolved on a 4% polyacrylamide gel (30:0.8 cross-linking) in 0.5x
Tris-borate EDTA. The gels were dried on Whatman 3MM paper
and subjected to autoradiography.
RESULTS
CdclOISctl Function Requires the Cdc2 Consensus
Site Within CdclO
The CdclO transcription factor is a phosphoprotein
in vivo (Simanis and Nurse, 1989), and analysis of
its primary structure revealed a single Cdc2 consen-
sus site (SPLR) at Ser-196. We therefore explored the
consequences of amino acid substitutions at Ser-196
by mutating this residue to the nonphosphorylat-
able alanine (S196A) and to the negatively charged
aspartic acid (S196D) to potentially mimic phos-
phorylation. These mutant cdclO genes were then
analyzed for their ability to complement the cdclO-
129 temperature-sensitive mutation. The cdclO+,
cdclO S196A, and cdclOS196D genes expressed on
plasmids under the control of the cdclO promoter
were transformed into a cdclO-129 strain (SP 965)
under permissive conditions for this mutation
(25°C). Individual transformants were then assayed
for growth under permissive or restrictive (36°C)
conditions. Transformants harboring an empty vec-
tor or the S196A mutant failed to grow at elevated
temperature, indicating that Ser-196 is essential for
CdclO function in vivo (Figure 1A). The S196D mu-
tant was, however, capable of fully complementing
the temperature-sensitive cdclO-129 mutation, sug-
gesting that phosphorylation of this residue is crit-
ical for CdclO function. The cdclO S196D mutant
displays a mild cell elongation phenotype indicative
of cell cycle delay, which is similar to that observed
upon overexpression of cdclO+/sctl+ (Ayte et al.,
1995).
The lack of cdclO-129 complementing activity by
cdclO S196A could be explained if this mutant gene
was not expressed or if its protein product was unsta-
ble. We therefore investigated the expression of
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Figure 1. Ser-196 is essential for CdclO function in vivo. (A) The cdclO-129 mutant strain was transformed with either cdclO+, cdclO S196A, or
cdclO S196D on a multicopy plasmid and grown on selective media at either 25'C (permissive) or 36'C (restrictive) as indicated. (B) Anti-CdclO
immunoblot of immunoprecipitates using either preimmune serum (lane 1) or the anti-CdclO antibody (lanes 2-7) from extracts prepared from cells
producing CdclO+ (lanes 2 and 3), CdclO S196A (lanes 4 and 5), or CdclO S196D (lanes 6 and 7) grown at either 25°C or 36'C as indicated.
cdcl0+, cdcl0 S196A, and cdcl0 S196D in the cdcl0-
129 transformants at both the permissive and nonper-
missive temperatures for this mutation (Figure 1B).
Individual transformants, expressing either cdcl0+,
cdcl0 S196A, or cdclOS196D were cultured at either 25
or 36°C, and cell-free lysates were prepared. CdclO
was immunoprecipitated with a polyclonal antibody
raised against full-length CdclO. The CdclO immuno-
precipitates were resolved by SDS-PAGE and then
transferred to nitrocellulose for Western blot analysis.
We found that the level of CdclO S196A was approx-
imately equal to that of Cdc1O+ in cells grown at 36°C.
Thus, a reduction in the level of CdclOS196A does not
account for its inability to complement the cdcl0-129
mutation.
CdclO Is Phosphorylated at Ser-196 In Vivo
We have demonstrated that Ser-196 is essential for
CdclO function in vivo. It was therefore of interest to
determine if this residue was phosphorylated in vivo.
Plasmids carrying the cdcl0+ or cdcl0 S196A genes
were transformed into a cdclO::ura sctl-1 strain, SP
1297, which contains no endogenous immunologically
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Figure 2. Ser-196 in CdclO is phosphorylated in vivo. 32P-labeled CdclO immunoprecipitates were resolved by SDS-PAGE, recovered from
gel slices, and subjected to proteolytic digestion with trypsin. The 32P-labeled tryptic peptides were resolved by two-dimensional chroma-
tography and visualized by phosphoimage analysis.
reactive CdclO (Marks et al., 1992). Cultures of these
transformants were labeled with [32P]orthophosphate
for the preparation of cell-free lysates, and CcdclO was
immunoprecipitated with a polyclonal antibody
raised against full-length CdclO. The Cdc1O immuno-
precipitates were resolved by SDS-PAGE and sub-
jected to autoradiography. The 32P-labeled CdclO pro-
tein was eluted from the gel and digested with trypsin.
The tryptic peptides were resolved by two-dimen-
sional chromatography, and the maps were visualized
by phosphoimage analysis (van der Geer et al., 1993;
Fuji Medical Systems USA, Stamford, CT). The tryptic
digestion of wild-type CdclO generated two major
spots (Figure 2, spots 1 and 2) and a minor spot (spot
3), whereas the digestion of CdclO S196A generated
only 1 major spot and a minor spot (spot 3); spot 2 is
clearly missing. This provides strong evidence that
Ser-196 in CdclO is phosphorylated in vivo.
The Association of CdclO with Sctl Is Not Cell
Cycle Dependent
Formation of the heteromeric Cdc1O/Sctl complex is
required for the activity of this transcription complex
(this work; Ayte et al., 1995). We investigated whether
the cell cycle periodicity of the DNA binding activity
of this complex was due to an oscillation in Cdc1O/
Sctl association across the cell cycle (Reymond et al.,
1993). S. pombe cells carrying a temperature-sensitive
allele of cdc25 (cdc25-22) display a tight cell cycle
arrest in G2 when shifted to the nonpermissive tem-
perature of 36°C and undergo synchronous cell divi-
sion upon reintroduction into media at the permissive
temperature (25°C) (Russell and Nurse, 1986). A cul-
ture of a strain (SP 530) carrying the cdc25-22 allele
harboring a plasmid expressing the sctl gene tagged at
the 3' end with a triple tandem copy of the hemagglu-
tinin (HA) epitope (Sctl-HA) was synchronized by
restricting growth at 36°C for 3 h (Caligiuri and Beach,
1993). The cells were then released into fresh media at
the permissive temperature of 25°C, and aliquots were
removed at 30-min intervals over a period of 6 h,
corresponding to two cell cycles. Cell-free extracts
were prepared, and the cell cycle profiles were moni-
tored by measuring septation index (Figure 3A). An-
ti-HA immunoprecipitates were resolved by SDS-
PAGE, transferred to a nitrocellulose membrane, and
probed with the anti-CdclO polyclonal antibody (Fig-
ure 3B). The results demonstrate that there are no
major and long-lasting fluctuations in the association
of CdclO with Sctl, but do not rule out the possibility
that a transient dissociation may occur in G1.
Inactivation of Cdc2 Leads to the Dissociation of
CdclO and Sctl
We have demonstrated that CdclO is inactivated when
Ser-196, which lies within a Cdc2 consensus site, is
mutated to alanine and that activity is restored when
it is replaced with aspartic acid. One possibility we
considered was that phosphorylation of CdclO on Ser-
196 was required for its association with Sctl. It was
therefore of interest to determine if the CdclO/Sctl
complex was dissociated upon loss of cdc2 in vivo. For
this purpose, protein extracts were prepared from a
wild-type strain and strains carrying the cdc2-33 and
cdc2-M72 mutations (SP 201, SP 357, and SP 1296,
respectively) harboring a plasmid expressing the
sctl-HA gene (Caligiuri and Beach, 1993). Cells that
carry the cdc2-33 and cdc2-M72 alleles are temperature
sensitive for growth. Both of these mutants arrest in
G1 and G2, although the cdc2-M72 mutant appears to
have a more profound G1 defect that the cdc2-33 mu-
tant. These extracts were immunoprecipitated with
either a polyclonal antibody raised against CdclO or
with a monoclonal antibody raised against the HA
epitope (12CA5). These immunoprecipitates were re-
solved by SDS-PAGE, and the proteins were trans-
ferred to nitrocellulose to visualize CdclO and Sctl by
Western blotting. The association between CdclO and
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Figure 3. Cdc 10 and Sct 1 are associated throughout the cell cycle.
A strain (SP 530) carrying a temperature-sensitive allele of cdc25
(cdc25-22) harboring a plasmid expressing the sctl-HA gene was
synchronized by arresting cell growth at the restrictive temperature
(36'C) for 3 h followed by release at the permissive temperature
(25'C). Aliquots of cells were removed at 30-min intervals after
release to permissive conditions for the preparation of cell-free
extracts. (A) The cell cycle profile was monitored by measuring the
percentage of septated cells at each time point. (B) Anti-HA immu-
noprecipitates were resolved by SDS-PAGE, transferred to a nitro-
cellulose membrane, and probed with an anti-CdclO antibody. The
lanes numbered 1-12 correspond to each 30-min interval with the
first lane corresponding to an an aliquot taken before release to the
permissive temperature.
Sctl seen in immunoprecipitates from extracts pre-
pared from wild-type cells (Figure 4A, lanes 8 and 9)
is abolished upon inactivation of Cdc2 by growth of
either the cdc2-33 or cdc2-M72 cells under restrictive
cdc2- cdc2-
WT 33 M72
11-- --
cL 27 36 27 36 27 36
l 2 3 4 5 6 7
Figure 4. The association between CdclO and Sctl is dependent
upon Cdc2 function in vivo. Cell-free extracts were prepared from
wild-type, cdc2-33, and cdc2-M72 strains producing Sctl-HA grown
at 27°C or 36°C as indicated. Immunoprecipitations were performed
using either the CdclO preimmune sera or normal mouse serum (A
and B, lane 1, respectively), the anti-CdclO antibody (A, lanes 2-7)
or the anti-HA antibody (A, lanes 8-13; B, lanes 2-7). These immu-
noprecipitates were resolved by SDS-PAGE, transferred to nitrocel-
lulose membranes, and probed with antibodies raised against CdclO
(A, lanes 1-13) or Sctl-HA (B, lanes 1-7) to visualize the CdclO and
Sctl-HA proteins, respectively.
conditions (36°C) and is thus not specific to a single
allele of cdc2 (Figure 4A, lanes 11 and 13). Growth of
the wild-type or cdc2 mutant strains at elevated tem-
perature had no effect on the level of CdclO (Figure
4A, lanes 3, 5, and 7). Similarly, the level of Sctl was
not affected in the wild-type or cdc2-33 strains grown
at elevated temperature, but was, however, reduced in
the cdc2-M72 strain (Figure 4B, lanes 3, 5, and 7). These
results suggest, therefore, that Cdc2 function, which
has been shown previously to be required for the
DNA binding activity of the complex (Reymond et al.,
1993), is required for the stabilization of the interaction
between Sctl and CdclO.
Ser-196 Within CdclO Is Essential for Association
with Sctl
The requirement for Cdc2 for CdclO/Sctl complex
formation suggests that the phosphorylation of either
CdclO or Sctl is required for their stable association.
As discussed above, CdclO is phosphorylated on Ser-
196, so we examined the possibility that the S196A
mutation inactivates CdclO by preventing its associa-
tion with Sctl. Sctl and CdclO were synthesized in
vitro in a coupled transcription/translation system in
rabbit reticulocyte lysate (Promega, Madison, WI)
Molecular Biology of the Cell
A
100
90
80
70
60
c
0
350
0
0 40
30
20
10
0
16
c
1110
Regulation of CdclO/Sctl Activity by Cdc2
IVT acdcl0
1 11 ri
1 2 3 4 5 6 7
203 -
105 -
71 - lelp
44-JSf
28- et
18-
2
10. 34
6 7
270 360
2I -
1 2 3 4 5 6 7
Q)
0..
8
Figure 5. Ser-196 within CdclO is essential
with Sctl. (A) Translation products labeled wil
locytes lysates programmed with Sctl, CdclO
Sctl and CdclO S196A resolved by SDS-PAGE
The CdclO+, CdclO+ Sctl, or CdclO S196A S
were immunoprecipitated with the anti-Cdcl(
by SDS-PAGE (lanes 5-7, respectively). (B) An
immunoprecipitates using the CdclO preimmi
extract (lane 1), the anti-CdclO antibody and C
CdclO S196D extracts (lanes 2-4, respectively
body and CdclO+, CdclO S196A, or CdclO SI
respectively). (C) Anti-CdclO immunoblot of in
cdc2-33 CdclO+, cdc2-33 CdclO S196A, and
extracts prepared from strains growing at 27
using the CdclO preimmune serum or norma
cdc2-33 CdclO+ (27°C) extract (lanes 1 and 8
CdclO antibody and cdc2-33 CdclO+, cdc,
cdc2-33 CdclO S196D extracts (lanes 2 and
respectively), and the anti-HA antibody
cdc2-33 CdclO S196A, or cdc2-33 CdclO S19
and 13, 11 and 14, respectively).
(Figure 5A, lanes 1 and 2, respecti
Sctl was cotranslated with CdclO1
(Figure 5A, lanes 3 and 4, respectix
cipitation of these 35S-labeled proteins with the anti-
CdclO antibody revealed that Sctl was associated with
CdclO+, but not, CdclO S196A (Figure 5A, lanes 6 and
7, respectively). This suggests that the S196A mutation
in CdclO does indeed prevent its association with Sctl,
perhaps due to the nonphosphorylatable nature of this
substitution. As described above Ser-196 is phosphor-
ylated in vivo, we therefore infer that an activity ca-
pable of the phosphorylation of CdclO is present in
these extracts.
We went on to examine the consequence of muta-
tions at Ser-196 in CdclO on complex formation with
Sctl in vivo. For this purpose, cell-free extracts were
prepared from wild-type strains (SP 812) producing
either CdclO+, CdclO S196A, or CdclO S196D and
Sctl-HA, grown at 27°C. Anti-CdclO (Figure 5B, lanes
2-4) and anti-HA (Figure 5B, lanes 5-7) immunopre-
cipitates were resolved by SDS-PAGE, blotted to ni-
trocellulose and probed with the anti-CdclO antibody.
Cdc1O+ and CdclO S196D were both found to be
associated with Sctl-HA (Figure 5B, lanes 5 and 7,
respectively), whereas CdclO S196A was not (Figure
5B, lane 6). All three forms of CdclO were clearly
detectable in these extracts (Figure 5B, lanes 2-4),
indicating that the loss of the association between
CdclO S196A and Sctl-HA was not due to a loss of
CdclO S196A protein. This result suggests that phos-
phorylation of CdclO at Ser-196 is required for its
stable association with Sctl.
As described above phosphorylation of CdclO at
270 36° Ser-196 appears to be required for CdclO to associate
with Sctl. Because Ser-196 lies within a Cdc2 consen-
-
_ sus site and Cdc2 is required for CdclO/Sctl complex
9 10 11 12 13 14 formation, we examined the possibility that CdclO
S196D might bypass this requirement because the neg-
for complex formation ative charge at residue 196 may mimic constitutive
th 3S from rabbit reticu- phosphorylation. To test this hypothesis, cell-free ex-
+, Sctl and CdclO+, or tracts were prepared from strains that carry the
(la translatonpecrodelyc)t cdc2-33 mutation and that produce CdclO+, CdclO
O antibody and resolved S196A, or CdclO S196D and Sctl-HA grown at 27°C
ti-CdclO immunoblot of and then shifted to 36°C for 3 h. As expected, CdclO+
une serum and CdclO+ and CdclO S196D were found to be associated with
'dclO+, CdclO S196A, or Sctl-HA in extracts prepared from the cdc2-33 strain
r) and the anti-H-A anti-
196D extracts (lanes 5-7, grown under permissive conditions (Figure 5C, lanes
nmunoprecipitates from 9 and 11, respectively), whereas CdclO S196A was not
cdc2-33 CdclO S196D (Figure 5C, lane 10). As shown above, inactivation of
'C or 36'C as specified, Cdc2 by growth under restrictive conditions led to the
I mouse serum and the loss of the association between CdclO+ and Sctl-HA1,respectively), the anti-
2-33 CdclO S196A, or (Figure 5C, lane 12). As predicted, CdclO S196D did, in
1 5, 3 and 6, 4 and 7, fact, associate with Sctl-HA under these conditions
and cdc2-33 CdclO+, (Figure 5C, lane 14) thus bypassing the requirement of6D (lanes 9 and 12, 10 Cdc2 for CdclO/Sctl complex formation. The inacti-
vation of Cdc2 did not alter the level of CdclO+,
CdclO S196A, or CdclO S196D protein (Figure 5C,
vely). In addition, lanes 2-7). The results of this experiment suggest that
F or CdclO S196A the role of Cdc2 in CdclO/Sctl complex formation is
Tely). Immunopre- in the phosphorylation of CdclO at Ser-196. The cdclO
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Figure 6. DNA-binding activity of
quires the Cdc2 consensus site within
were performed with the cdc22 pron
prepared from cdclO-129 strains prc
1-4 and 9 and 10), CdclO S196A (lan
CdclO S196D (lanes 7 and 8 and 13
grown under permissive conditions fc
then extracts were prepared and incub
or 32°C (lanes 9-14) for 15 min in vi
promoter fragment in the absence
contains a binding reaction with a 5
promoter fragment.
S196D gene did not, however,
the cdc2 mutant, indicating th
Sctl complex formation is no
formed by Cdc2 in the execut
lished observations).
32CC the cdc22 promoter fragment was abolished when the
phosphorylation of CdclO at Ser-196 was prevented by
mutation. The DNA binding activity of the CdclO/
>
-Br Sctl complex produced in the cdclO-129 strain is
greatly reduced relative to wild type when assayed
under permissive conditions and is completely abol-
ished under restrictive conditions (Lowndes et al.,
T2 CD CD CDo1992a; Caligiuri and Beach, 1993). We therefore trans-
-z -z- formed this strain with plasmids expressing cdclO+,1j W cdclO S196A, and cdclO S196D to assay the DNA-
_
- ,,,,_binding activity of these phosphorylation site mu-
tants. For this purpose, protein extracts were prepared
from these transformants grown under permissive
conditions for the cdclO-129 mutation and incubated
at either 25°C or 32°C for 15 min in vitro. As shown in
* S Figure 6, a specific band was detected when the extract
prepared from the strain producing CdclO+ was in-
cubated with the cdc22 promoter fragment (Figure 6,
lane 2). The specificity of the reaction is shown by the
loss of the DNA binding activity when an excess of
cold competitor fragment was included in the reaction
(Figure 6, lane 3) and by the supershift of the DNA/
protein complex into the well of the gel observed upon
addition of the anti-cdclO antibody (Figure 6, lane 4).
In contrast, a very weak DNA-binding activity is de-
tected in the extract prepared from the cdclO-129
CdclO S196A strain when assayed under permissive
*IZguiZ s sconditions (Figure 6, lane 5). The low activity in this
extract indicates that CdclO S196A is incapable of
complementing the endogenous activity and that the
S196A mutation renders CdclO inactive. It does nott<11 l2 13 1:4 appear that CdclO S196A prevents the gel shift as the
level of activity seen in this experiment is similar to
CdclOSGelretalrdaconplessarys that observed with cdclO-129 extracts (Lowndes et al.,
noter fragment using extracts 1992a; Caligiuri et al., 1993). CdclO S196D was found
ducing either CdclO+ (lanes to restore the DNA-binding activity to the level ob-
ies 5 and 6 and 11 and 12), or tained with CdclO+ (Figure 6, lane 7). This complex is
3 and 14). The cultures were supershifted into the well upon addition of the anti-
ir the cdclO-129 mutation, and
)ated at either 250C (lanes1-8) CdclO antibody as n the wild-type case, idicatng
tro. Lane 1 contains the cdc22 that CdclO S196D is, in fact, present in this DNA/
f protein extract, and lane 2 protein complex (Figure 6, lane 8). When these extracts
O-fold M excess of unlabeled were incubated at 32°C the DNA-binding activity in
the CdclO S196A extract was completely abolished
(Figure 6, lane 11) whereas that from the CdclO+ and
CdclO S196D extracts was approximately the same as
rescue the G, defect of in the extracts incubated at 25°C (Figure 6, lanes 9 and
at promotion of CdclO/ 13, respectively). These results indicate that the cdclOit the sole function per- S196A mutation destroys the CdclO/Sctl DNA bind-ion of Start (our unpub- ing activity and suggests that phosphorylation of
CdclO at Ser-196 is essential for this activity.
CdclO/Sctl DNA-binding Activity Requires the Cdc2
Consensus Site Within CdclO
Cdc2 has been shown to be required for CdclO/Sctl
complex formation and DNA-binding activity (this
study; Reymond et al., 1993). It was therefore of inter-
est to determine whether the binding of CdclO/Sctl to
DISCUSSION
The biochemical and genetic results presented in this
article support a molecular model for the regulation of
Start in which the Cdc2 protein kinase functions to
control CdclO/Sctl complex formation. Our data
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demonstrate that the formation of the CdclO/Sctl
transcription complex requires the activity of the Cdc2
protein kinase. We provide data demonstrating that
Ser-196 in CdclO, which lies within a Cdc2 consensus
site, is phosphorylated in vivo. Phosphorylation of
this serine is essential for CdclO function. Substitution
of this serine with alanine (S196A) results in a loss of
complementing activity in vivo. We show that this is
due to the inability of the CdclO S196A mutant to
associate with Sctl in vivo. As a consequence, the
Sctl /CdclO transcription complex is incapable of
binding to its target promoters. It is formally possible
that CdclO S196A does not localize properly to the
nucleus, which could thus account for its lack of com-
plementing activity (Reymond et al., 1993). The find-
ing, however, that CdclO+ associates with Sctl in
vitro, whereas CdclO S196A does not, suggests that if
this is the case complex formation precedes nuclear
localization. Substitution of this serine with aspartic
acid, potentially mimicking phosphorylation, restores
the ability of CdclO to complex with Sctl and thus its
function in vivo. Interestingly, the CdclO S196D mu-
tation bypasses the requirement for Cdc2 activity in
Sctl /CdclO complex formation. We therefore propose
that the Cdc2 protein kinase functions to control the
affinity of CdclO for its cognate partner, Sctl.
The demonstration that CdclO S196D alleviates the
requirement of Cdc2 for its association with Sctl
strongly implicates the involvement of Cdc2 in the
phosphorylation of Ser-196. In the accompanying ar-
ticle (Caligiuri et al., 1997), we demonstrate that the
Ranl kinase is also involved in Ser-196 phosphoryla-
tion. Thus, we conclude that Ranl and Cdc2 function
together to control the phosphorylation of CdclO at
Ser-196. It is currently unclear which kinase acts di-
rectly to phosphorylate CdclO. Ran 1 has been impli-
cated as a mediator of the cellular response to nutri-
tional deprivation. In this respect, CdclO, whose
phosphorylation state may influence the developmen-
tal program, leading to either cellular proliferation or
differentiation, may be a substrate of both the Cdc2
and Ran 1 kinases under conditions of cellular stress.
It is clear that CdclO has at least two DNA binding
partners, Sctl and Pctl, giving rise to two distinct
heteromeric DNA-binding complexes (Caligiuri and
Beach, 1993; Miyamoto et al., 1994; Zhu et al., 1994).
Genetic analyses of strains deleted for sctl or pctl
demonstrate that their roles in the cell cycle are, in
fact, different. The pctl gene is not essential for mitotic
cell cycle progression, null mutants do not display
adverse effects on cell viability or growth rate (Miya-
moto et al., 1994; Zhu et al., 1994). Deletion of sctl is,
however, a lethal event resulting simultaneously in G,
arrest and derepression of mating functions (Caligiuri
and Beach, 1993). Although sctl null mutants are de-
repressed for meiosis, it appears that the meiotic path-
way can proceed normally (Caligiuri and Beach, 1993).
In contrast, the pctl gene product appears to play a
major role in meiosis, which is severely disrupted in
the null mutant (Miyamoto et al., 1994; Zhu et al.,
1994). These results suggest that Sctl plays a more
critical role in the mitotic cell cycle than Pctl, which
appears to function predominantly in meiosis, al-
though Pctl can contribute to the transcriptional reg-
ulation at Start under some circumstances (Miyamoto
et al., 1994; Zhu et al., 1994).
The sctl and pctl genes are both expressed during
mitotic growth though pctl is greatly induced upon
nitrogen starvation, thus their protein products are
present simultaneously in the cell (Miyamoto et al.,
1994; Zhu et al., 1994). The ratio of the Sctl/CdclO
complex to the Pctl/CdclO therefore may be regu-
lated by the phosphorylation state of CdclO. In this
case, CdclO phosphorylated on Ser-196 may display a
higher affinity for Sctl, and conversely, unphosphor-
ylated CdclO (at least with respect to this site) may
display a higher affinity toward Pctl. It is conceivable
that phosphorylation of CdclO at Ser-196 is not re-
quired for Pctl /CdclO function because unlike CdclO,
Sctl, and Cdc2, loss of Pctl does not lead to G, arrest(Miyamoto et al., 1994; Zhu et al., 1994). Upon loss of
Cdc2, CdclO may become under-phosphorylated at
specific residues and the Pctl/CdclO complex would
dominate. Cells that arrest in G1 then would be com-
petent to exit the cell cycle and activate mating func-
tions under appropriate nutritional conditions if chal-
lenged by a cell of the opposite mating type. It follows
that the sctl null mutant is derepressed for meiotic
activation simply because Sctl is not present to com-
pete with Pctl for its cognate partner, CdclO. Alterna-
tively, another kinase could phosphorylate CdclO
upon meiotic activation. When cells are starved for
nitrogen, no significant change in the level of CdclO is
detected and CdclO remains phosphorylated (Simanis
and Nurse, 1989). Subtle changes in phosphorylation
sites may occur, however, and thereby account for
potential differences in the affinity of CdclO for either
Sctl or Pctl. It will be interesting to determine
whether the presence of the canonical Cdc2 phosphor-
ylation site in CdclO is necessary for its association
with Pctl.
A number of transcription factors contain ankyrin
repeat motifs and achieve specificity in transcriptional
regulation through formation of specific heteromeric
complexes (Thompson et al., 1991; Sawanda et al.,
1994). It has been suggested that ankyrin repeats play
an important role by providing an interface for pro-
tein-protein interactions (Thompson et al., 1991). The
CdclO/Sctl proteins, which both contain a pair of
ankyrin repeats, thus possess hallmarks of an evolu-
tionarily conserved mechanism to regulate gene ex-
pression. The results presented here indicate that a
specific phosphorylation in a non-ankyrin-like domain
dramatically influences the ability of one protein to
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stably associate with its heteromeric partner and form
an active DNA-binding complex. It is thus possible
that phosphorylation will play an important and con-
served role in controlling the highly specific interac-
tions among these proteins to regulate key develop-
mental processes.
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